LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
Date first appeared online 31/12/2016
DOI 10.1186/s12933-016-0341-5
Authors Bain S.
Journal Name Cardiovascular Diabetology
Volume 15

Documents